| abstract |
(57) [Summary]nThe invention relates to the medical field. The essence of the present invention is a drug based on a viable culture of Bacillus bacillus, which is a recombinant strain of Bacillus subtilis producing human α2-interferon, a certain percentage of live viable Bacillus licheniformis, It is to provide a medicament comprising a loading compound. This drug is for treating viral infections such as hepatitis, herpes and encephalitis, bacterial infections such as enteritis, colitis, chlamydiasis, vaginitis, and immunodeficiency symptoms. The present invention extends the scope of non-invasive methods of treating bacterial, viral and immunodeficiency conditions. |